These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34460979)

  • 1. Clinical features and genetic defect in six index patients with congenital fibrinogen disorders: Three novel mutations with one common mutation in Taiwan's population.
    Shen MC; Wang JD; Tsai W; Lin CY; Lin JS; Kuo SF; Lin PT; Huang YC; Hung MH
    Haemophilia; 2021 Nov; 27(6):1022-1027. PubMed ID: 34460979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and clinical profile of congenital fibrinogen disorders in Iran, identification of two novel mutations.
    Tavasoli B; Safa M; Dorgalaleh A; Ghasemi JB; Rezaei Makhouri F; Rezvani MR; Ahmadi A; Tabibian S; Jazebi M; Baghaipour MR; Zaker F
    Int J Lab Hematol; 2020 Oct; 42(5):619-627. PubMed ID: 32639687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and clinical characterization of congenital fibrinogen disorders in Polish patients: Identification of three novel fibrinogen gamma chain mutations.
    Wypasek E; Klukowska A; Zdziarska J; Zawilska K; Treliński J; Iwaniec T; Mital A; Pietrys D; Sydor W; Neerman-Arbez M; Undas A
    Thromb Res; 2019 Oct; 182():133-140. PubMed ID: 31479941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital fibrinogen disorder caused by digenic mutations of the
    Wang X; Tang N; Shen N; Lu Y; Li D
    Hematology; 2020 Dec; 25(1):145-148. PubMed ID: 32228225
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical and molecular characterization of Iranian patients with congenital fibrinogen disorders.
    Mohsenian S; Seidizadeh O; Mirakhorli M; Jazebi M; Azarkeivan A
    Transfus Apher Sci; 2021 Dec; 60(6):103203. PubMed ID: 34275736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital afibrinogenemia: Identification and characterization of two novel homozygous fibrinogen Aα and Bβ chain mutations in two Tunisian families.
    Amri Y; Toumi Nel H; Hadj Fredj S; de Moerloose P
    Thromb Res; 2016 Jul; 143():11-6. PubMed ID: 27164460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of the fibrinogen gene cluster in 16 patients with congenital afibrinogenemia: novel truncating mutations in the FGA and FGG genes.
    Neerman-Arbez M; de Moerloose P; Honsberger A; Parlier G; Arnuti B; Biron C; Borg JY; Eber S; Meili E; Peter-Salonen K; Ripoll L; Vervel C; d'Oiron R; Staeger P; Antonarakis SE; Morris MA
    Hum Genet; 2001 Mar; 108(3):237-40. PubMed ID: 11354637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations Accounting for Congenital Fibrinogen Disorders: An Update.
    Richard M; Celeny D; Neerman-Arbez M
    Semin Thromb Hemost; 2022 Nov; 48(8):889-903. PubMed ID: 35073585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Congenital afibrinogenemia caused by a novel insertion mutation in the FGB gene].
    Zhang J; Zhao XJ; Wang ZY; Yu ZQ; Cao LJ; Ma ZN; Zhang J; Zhang W; Bai X; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2013 Sep; 34(9):751-6. PubMed ID: 24103871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational Epidemiology of Congenital Fibrinogen Disorders.
    Casini A; Blondon M; Tintillier V; Goodyer M; Sezgin ME; Gunes AM; Hanss M; de Moerloose P; Neerman-Arbez M
    Thromb Haemost; 2018 Nov; 118(11):1867-1874. PubMed ID: 30332696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Two Novel Fibrinogen Bβ Chain Mutations in Two Slovak Families with Quantitative Fibrinogen Disorders.
    Simurda T; Zolkova J; Snahnicanova Z; Loderer D; Skornova I; Sokol J; Hudecek J; Stasko J; Lasabova Z; Kubisz P
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29286337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinogen gene mutations accounting for congenital afibrinogenemia.
    Neerman-Arbez M
    Ann N Y Acad Sci; 2001; 936():496-508. PubMed ID: 11460507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of 7 patients affected by dys- or hypo-dysfibrinogenemia: Identification of a novel mutation in the fibrinogen Bbeta chain causing a gain of glycosylation.
    Asselta R; Robusto M; Platé M; Santoro C; Peyvandi F; Duga S
    Thromb Res; 2015 Jul; 136(1):168-74. PubMed ID: 26006300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal diagnosis for congenital afibrinogenemia caused by a novel nonsense mutation in the FGB gene in a Palestinian family.
    Neerman-Arbez M; Vu D; Abu-Libdeh B; Bouchardy I; Morris MA
    Blood; 2003 May; 101(9):3492-4. PubMed ID: 12511408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel fibrinogen variant in a Chinese pedigree with congenital dysfibrinogenemia caused by FGA P. Arg38Thr mutation: A case report.
    Cai R; Li Y; Wang W; Gao X; Liu M; Diao Y; Tang Y; Feng Q
    Medicine (Baltimore); 2018 Oct; 97(40):e12697. PubMed ID: 30290666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital fibrinogen disorders: an update.
    de Moerloose P; Casini A; Neerman-Arbez M
    Semin Thromb Hemost; 2013 Sep; 39(6):585-95. PubMed ID: 23852822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital hypofibrinogenemia associated with novel homozygous fibrinogen Aα and heterozygous Bβ chain mutations.
    Castaman G; Rimoldi V; Giacomelli SH; Duga S
    Thromb Res; 2015 Jul; 136(1):144-7. PubMed ID: 25981141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical phenotype and laboratory characteristics of 93 patients with congenital fibrinogen disorders from unrelated 36 families.
    Tian D; Liang J; Gao H; Xu X; Nie W; Yin M; Lou J; Shen HQ
    Res Pract Thromb Haemost; 2024 May; 8(4):102445. PubMed ID: 38953055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the fibrinogen aalpha gene account for the majority of cases of congenital afibrinogenemia.
    Neerman-Arbez M; de Moerloose P; Bridel C; Honsberger A; Schönbörner A; Rossier C; Peerlinck K; Claeyssens S; Di Michele D; d'Oiron R; Dreyfus M; Laubriat-Bianchin M; Dieval J; Antonarakis SE; Morris MA
    Blood; 2000 Jul; 96(1):149-52. PubMed ID: 10891444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of bleeding and thrombosis in inherited qualitative fibrinogen disorders.
    Castaman G; Giacomelli SH; Biasoli C; Contino L; Radossi P
    Eur J Haematol; 2019 Oct; 103(4):379-384. PubMed ID: 31314131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.